NCT01231347 2024-07-16
GAMMA
NantCell, Inc.
Phase 3 Completed
Clinical Trials
4 trialsNCT06276738 2024-05-14
The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease
Adenocyte, LLC
Not yet recruiting
NCT02098239 2014-03-27
Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.
Cancer Advances Inc.
Phase 2 Completed
NCT00196105 2011-10-03
Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)
Cook Group Incorporated
Phase NA Completed